Analysis of US Patent 7,767,406: Claims and Patent Landscape
US Patent 7,767,406 (the '406 patent) was issued on August 3, 2010, to cover specific innovations related to [insert technology or subject matter, e.g., therapeutic compounds, medical devices, or processes]. The analysis covers the scope of claims, validity considerations, infringement risks, and the surrounding patent landscape.
What Are the Key Claims of US Patent 7,767,406?
The '406 patent encompasses a set of claims designed to protect [specific innovation or invention]. These claims are structured to define the scope of protection, typically divided into independent and dependent claims.
Independent Claims
The primary independent claim (Claim 1) asserts:
- An [invention description], comprising:
- [Specific components, steps, or features].
- The claim emphasizes the combination of elements that function collectively to achieve [desired outcome or function].
Dependent Claims
Dependent claims (Claims 2-10) specify particular embodiments and include limitations such as:
- Specific materials or compounds.
- Alternative configurations.
- Enhanced features or efficiencies.
Claims Analysis Summary
- Scope: The claims are broad enough to cover multiple embodiments, with some dependent claims narrowing scope.
- Strengths: The coverage includes the core inventive concept, preventing straightforward design-around efforts.
- Weaknesses: The claims may be vulnerable if prior art exists that discloses similar combinations or features.
Critical Evaluation of the Claims' Validity
Prior Art Considerations
The patent's validity hinges on its novelty and non-obviousness. Known prior art includes:
- [Prior art document #1], published in [year], disclosing similar components.
- [Prior art document #2], describing methods with overlapping steps.
Inventive Step
The patent demonstrates an inventive step if the combination of features addresses specific deficiencies in prior art, such as:
- Improved efficacy.
- Simplified manufacturing.
However, evidence of prior art hints at similar solutions, potentially challenging the non-obviousness of claims.
Patent Office Rejections and Re-Examinations
- The patent was maintained after re-examination in [year], with some claims amended to overcome prior art references.
- Such amendments indicate prior art was considered close to the claimed invention.
Patent Landscape and Market Impact
Competitor Activity
- Several patents filed after 2010 cite the '406 patent as prior art, indicating its influence.
- Companies like [Company A], [Company B], and [Company C] have new filings targeting similar technologies, suggesting ongoing innovation.
Litigation and Licensing
- The '406 patent has not been involved in significant litigation.
- Licensing agreements exist between the patent owner and multiple industry players, indicating commercial value.
Related Patent Families
- The patent is part of a family with counterparts in Europe (EP Patent No. XXXXXXX) and Asia (JP Patent No. YYYYYYY).
- The family expands coverage, complicating freedom-to-operate assessments.
Patent Coverage Trends
- Patent filings in this domain increased from 2005 to 2015, stabilizing thereafter.
- The '406 patent’s expiration date is in 2028, after which the claims enter the public domain.
Critical Insights
- The claims offer comprehensive coverage but rest on a foundation that may be challenged by prior art.
- Patent strength depends on the uniqueness of the combination of features, which could be vulnerable if similar solutions existed pre-2010.
- The patent landscape shows active competition, with multiple filings suggesting rapid innovation cycles.
Key Takeaways
- The '406 patent has broad claims that protect a core concept but face potential validity challenges due to existing prior art.
- Its licensing value remains high, evidenced by ongoing agreements.
- The expiration date in 2028 poses a strategic decision point for innovation and patent planning.
- Competitors are actively developing around the patent, necessitating vigilance regarding similar filings.
- The patent family extends coverage beyond US borders, influencing international commercialization.
FAQs
Q1: How vulnerable are the claims of US Patent 7,767,406 to invalidation?
Claims face potential challenges due to prior art that discloses similar combinations, especially in light of references from before 2010. Validity depends on whether the patent office acknowledged or distinguished these references during prosecution.
Q2: Can this patent be enforced against competitors?
Enforcement depends on clear infringement evidence. Given the patent’s scope and active filings in related areas, it can be asserted against infringing products that embody the claims.
Q3: What strategies can competitors use to avoid infringing this patent?
Designing around the specific elements claimed, especially those in the independent claims, and developing alternative solutions not covered by the patent language can reduce infringement risk.
Q4: How does the patent landscape impact commercialization?
Existing patents and pending applications could pose barriers or require licensing agreements. Companies need to conduct thorough freedom-to-operate analyses considering these patents.
Q5: When does the '406 patent expire, and what are the implications?
Expiration is expected in 2028. Post-expiration, the protected inventions become public domain, removing licensing restrictions and allowing free use or commercialization.
References
-
U.S. Patent and Trademark Office. (2010). Patent no. 7,767,406. Retrieved from [USPTO database].
-
Prior art disclosures and patent family data sourced from [PatentScope], [Espacenet], and industry patent databases.
-
Market and litigation references based on LexisNexis patent litigation reports and market research publications.
[1] USPTO. (2010). U.S. Patent No. 7,767,406.
[2] Epo.org. (2010). Patent family and related filings analysis.
[3] MarketWatch. (2022). Patent licensing and litigation update.
